Quanterix: Trading Below 1x Sales Despite A Changing Story (NASDAQ:QTRX)
· seekingalpha.com
Quanterix (QTRX) turnaround: new management, Akoya synergies, biomarker growth and Alzheimer’s blood test. Cash-flow breakeven H2 2026.
My name is María Fernanda and I'm currently studying an MBA. My inspiration investors are Warren Buffett, Peter Lynch and Terry Smith, so I look for quality co...